Managing type 2 diabetes requires more than just willpower — it demands the right medication, taken correctly, at the right time. Metformin Hydrochloride Sustained Release (SR) Tablets have emerged as one of the most trusted, evidence-backed medicines for blood sugar management worldwide.
Whether you are a patient newly prescribed this tablet, a caregiver, or a healthcare professional seeking clear product information, this guide covers everything you need to know about metformin hydrochloride sustained release tablets — including their uses, how they work, dosage guidance, precautions, and more.
| 🔑 Quick Answer: Metformin Hydrochloride SR 500 mg Tablets are used to treat type 2 diabetes mellitus by reducing blood sugar levels. They work by limiting sugar production in the liver, slowing sugar absorption from the gut, and improving insulin sensitivity — all in a slow, sustained manner over time. |
Table of Contents
ToggleMetformin is an oral anti-diabetic medicine that belongs to the biguanide class of drugs. It has been used for over 60 years and is listed on the World Health Organization’s (WHO) Model List of Essential Medicines.
The hydrochloride (HCl) form — metformin hydrochloride — is the pharmaceutical salt version of metformin that the body can absorb effectively. When formulated as a sustained-release (SR) tablet, the active ingredient is released gradually over several hours, offering a smoother and more consistent effect compared to standard immediate-release versions.
Immediate-Release Tablets: Release the drug quickly; must be taken 2–3 times daily; more likely to cause stomach side effects.
Sustained Release (SR) Tablets: Release the drug slowly over 8–12 hours; can often be taken once daily; generally better tolerated by the stomach.
Key Benefit of SR Formulation: Fewer gastrointestinal side effects (nausea, diarrhea) and improved patient compliance.
The primary use of metformin hydrochloride sustained-release tablets is the management of type 2 diabetes mellitus. However, it is also used in several other clinical situations.
Primary Use: Type 2 Diabetes Mellitus
Metformin is the first-line medicine recommended by the American Diabetes Association (ADA), the World Health Organization (WHO, and most national treatment guidelines for type 2 diabetes. It is prescribed when diet and exercise alone are not enough to control blood sugar levels.
Other Recognised Uses of Metformin HCl SR Tablets
Understanding the mechanism of action helps appreciate why metformin is so effective and why the SR formulation is preferred.
Three Key Actions of Metformin in the Body
Reduces liver sugar production: The liver naturally releases glucose into the bloodstream — especially overnight. In type 2 diabetes, the liver overproduces glucose. Metformin directly reduces this process, significantly lowering fasting blood sugar levels.
Slows sugar absorption from the gut: Metformin slows down how quickly carbohydrates are absorbed from the digestive tract into the bloodstream. This prevents sharp spikes in blood sugar after meals.
Improves insulin sensitivity: Metformin makes the body’s cells more responsive to insulin. This means the same amount of insulin can move more glucose out of the blood and into the cells, where it is used for energy.
The sustained release formulation ensures these three mechanisms operate consistently throughout the day, without sudden peaks or drops in drug levels in the blood.
Novalab Healthcare manufactures Metformin Hydrochloride Sustained Release Tablets IP 500 mg under the brand name CONIMET-500 SR. Here is a clear overview of this product:
What Does ‘IP’ Mean on the Label?
‘IP’ stands for Indian Pharmacopoeia — the official standard set by the Government of India for drug quality, purity, and strength. A tablet labelled as Metformin Hydrochloride Sustained Release Tablets IP guarantees that it meets rigorous quality control standards, making it safe and effective for medical use.
Correct usage of metformin sustained-release 500 mg tablets is essential for effectiveness and safety. Always follow your doctor’s prescription — the information below is for general education only.
General Dosage Guidelines
Important Directions for Use
Metformin HCl sustained-release tablets have several important advantages over other diabetes medicines:
While metformin is generally safe, certain conditions require caution. Inform your doctor about your complete medical history before starting these tablets.
Do Not Take Metformin If You Have:
Inform Your Doctor If You Have:
The sustained release formulation of metformin is specifically designed to reduce side effects, but some may still occur — especially at the start of treatment.
Common Side Effects (Usually Mild and Temporary)
These effects typically improve within 1–2 weeks as your body adjusts. Taking the tablet with food significantly reduces stomach discomfort.
Rare but Serious: Lactic Acidosis
Lactic acidosis is a very rare but serious side effect where lactic acid builds up in the blood. Symptoms include: unusual muscle pain, difficulty breathing, stomach discomfort, feeling cold or dizzy, or feeling very weak. Seek immediate medical attention if you experience these symptoms.
CONIMET-500 SR is manufactured by Novalab Healthcare Pvt. Ltd., a research-based pharmaceutical company based in Panchkula, Haryana (India). Novalab is committed to producing high-quality, affordable medicines that meet Indian Pharmacopoeia (IP) standards.
Novalab Healthcare offers this product for third-party manufacturing, PCD pharma franchise, and direct supply — making it accessible to pharma distributors, healthcare providers, and stockists across India.
Q. What are metformin hydrochloride sustained-release tablets used for?
Metformin Hydrochloride Sustained Release Tablets are primarily used to treat type 2 diabetes mellitus. They help control blood sugar by reducing the liver’s glucose output, slowing sugar absorption from the digestive tract, and improving the body’s response to insulin. They are also used for prediabetes and polycystic ovary syndrome (PCOS).
Q. What is the difference between metformin SR and regular metformin tablets?
Regular (immediate-release) metformin tablets release the drug rapidly and are usually taken 2–3 times a day. Metformin SR (sustained release) tablets release the drug gradually over 8–12 hours, allowing for once-daily dosing in many cases. The SR formulation also causes fewer gastrointestinal side effects like nausea and diarrhoea, making it better tolerated.
Q. Can metformin HCl sustained-release tablets cause low blood sugar (hypoglycemia)?
No — when used as a single medicine, metformin does not cause hypoglycemia (dangerously low blood sugar). This is one of its key advantages over other diabetes medicines like sulfonylureas or insulin. However, if metformin is combined with those medicines, low blood sugar may occur.
Q. How should I take metformin hydrochloride IP 500 mg tablets?
Always take metformin hydrochloride sustained release tablets with food — ideally with your evening meal. Swallow the tablet whole; do not crush, chew, or break it, as this destroys the sustained release mechanism. Take it at the same time every day. Do not stop without consulting your doctor, even if your blood sugar appears normal.
Q. Is metformin safe for long-term use?
Yes. Metformin has one of the best long-term safety records of any diabetes medicine, backed by over 60 years of clinical use. Long-term use may reduce vitamin B12 absorption, so your doctor may recommend periodic B12 monitoring. Kidney function should also be checked regularly to ensure the medicine continues to be processed safely.
Q. Who should not take metformin hydrochloride sustained-release tablets?
People with severe kidney disease (eGFR below 30), significant liver disease, diabetic ketoacidosis, metabolic acidosis, or a known allergy to metformin should not take these tablets. Patients undergoing contrast dye procedures or major surgery may also need to temporarily stop metformin. Always consult your doctor before starting or stopping this medication.
Q. Are metformin HCl SR tablets IP available for pharma franchise or third-party manufacturing?
Yes. CONIMET-500 SR (Metformin Hydrochloride Sustained Release Tablets IP 500 mg) by Novalab Healthcare is available for PCD pharma franchise, third-party manufacturing, and wholesale supply across India. Interested parties can contact Novalab Healthcare directly at +91-9570599567 or visit www.novalabgroup.in to send an enquiry.
We are a research-based pharmaceutical company. The mission of Novalab Healthcare is to improve the health of the Indian community by providing them with quality.
Copyright by © 2026 Novalab Healthcare | Marketing By Digify Ads
